| Product Name |
MF |
CAS |
Details |
| Alpha-Naphthoflavone |
C19H12O2 |
604-59-1 |
|
| 2-[[5-Methoxy-1-[4-(trifluoromethyl)phenyl] pentylidene]amino]oxyethanamine |
C19H25F3N2O6 |
917096-37-8 |
|
| 2-Amino 4-methyl thio aniline |
C7H10N2S |
67469-02-7 |
|
| Methyl 3-amino-4-methylthiophene-2-carboxylate |
C7H9NO2S |
85006-31-1 |
|
| Alantolactone |
C15H20O2 |
546-43-0 |
|
| 4-Nitrophenyl butyrate |
C10H11NO4 |
2635-84-9 |
|
| Benzofuran-6-carboxylic acid |
C9H6O3 |
77095-51-3 |
|
| 1-{1-[4, 4-Bis (4-Fluorophenyl) but-3-en-1-yl] piperidin- 4-yl} benzimidazolin-2-one |
C28H27F2N3O |
1347746-73-9 |
|
| 4-Fluoro-5-{[(2R)-2-methyl-1,4-diazepan-1- yl]sulfonyl}isoquinoline Hydrochloride |
C15H19ClFN3O2S |
223644-04-0 |
|
| Methyl-3(2-bromoacetyl) benzoate |
C10H9BrO3 |
27475-19-0 |
|
| 2-Amino-3-methylbenzamide |
C8H10N2O |
1885-32-1 |
|
| 3-Oxo-4-aza-5α-αndrost-1-ene-173-carboxylic acid methyl ester |
C20H29NO3 |
103335-41-7 |
|
| Nelarabine |
C11H15N5O5 |
121032-29-9 |
|
| 4-Ethylpyrimidine |
C6H8N2 |
30537-73- 6 |
|
| 1-(9H-Carbazol-4-yloxy)-3-[[3-(9H-carbazol-4-yloxy)-2- hydroxypropyl]-[2-(2-methoxyphenoxy) ethyl] amino] propan-2-ol |
C39H39N3O6 |
918903-20-5 |
|
| 2-[1-[(3-Oxo-2-azaspiro [4.5]decan-2- yl)methyl]cyclohexyl]acetic acid |
C18H29NO3 |
1076198-17-8 |
|
| HATU |
C10H15F6N6OP |
148893-10-1 |
|
| 4-(7-methoxy-2,2-dimethyl-3-phenyl-chroman-4-yl)-phenol |
C24H24O3 |
57897-46-8 |
|
| N-(2-Hydroxy-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide |
C19H24N2O4 |
128954-45-0 |
|
| Dibenzofuran-2-carboxaldehyde |
C13H8O2 |
5397-82-0 |
|
| Hibifolin |
C21H18O14 |
55366-56-8 |
|
| Tetrahydroharmine |
C13H16N2O |
17019-01-1 |
|
| 2-(3-bromo-4-cyclohexylphenyl)ethanol |
|
1898038-55-5 |
|
| 5-(hydroxymethyl)
pyrimidine-2,4(1H,3H)-dione |
C5H6N2O3 |
4433-40-3 |
|
| 8-Hydroxy-2-methylquinoline 98% |
C10H9NO |
826-81-3 |
|
| 6-Fluoro-3-hydroxy pyraine-2-carboxamide |
C5H4FN3O2 |
259793-96-9 |
|
| 3-BROMO-5-FLUORO-2-IODOTOLUENE |
C7H5BrFI |
1000576-60-2 |
|
| Harmine |
C13H12N2O |
442-51-3 |
|
| 5-Deoxy-L-ribose ;(2S,3S,4S)-2,3,4-trihydroxypentanal |
C5H10O4 |
18555-65-2 |
|
| N1,N4-dicyanopiperazine-1,4-bis(carboximidamide) |
C8H12N8 |
19803-86-2 |
|
| 7,8-Dimethoxycoumarin |
C11H10O5 |
486-21-5 |
|
| 3-BROMO-5-HYDROXY BENZALDEHYDE |
C7H5BrO2 |
199177-26-9 |
|
| 3-Chloro-5- hydroxybenzonitrile |
C7H4ClNO |
473923-97-6 |
|
| 2-Amino-5-bromo benzoic acid |
C7H6BrNO2 |
5794-88-7 |
|
| 2-Amino-5-bromo-3-nitro pyridine |
C5H4BrN3O2 |
6945-68-2 |
|
| Zanubrutinib impurity-1; ((S)-2-(4-Phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide) |
C24H27N5O2 |
1633352-71-2 |
|
| 2-Methylthiophenothiazine |
C13H11NS2 |
7643-08-5 |
|
| Diazoxide impurity-2 (2-acetamido-5-chlorobenzenesulfonic acid; 5-Chloro diazoxide) |
C8H8ClNO4S |
54981-41-8 |
|
| 2, 4 -dibromo-1-6-Methylpyrimidine |
C5H4Br2N2 |
2054922-16-4 |
|
| Zanubrutinib cyano Impurity; ((S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carbonitrile) |
C27H27N5O2 |
2432022-47-2 |
|
| Cyclopentyl (2,3-bis(2-Methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5- yl)carbamate |
C47H48N4O10S2 |
1160235-26-6 |
|
| Propane, 1-(methylsulfonyl)- |
C4H10O2S |
1977-37-3 |
|
| 4-BROMO-1,2-DINITROBENZENE |
C6H3BrN2O4 |
610-38-8 |
|
| TERT BUTYL NITRITE |
C4H9NO2 |
540-80-7 |
|
| 2-(5-Methoxy-1H-indol-3-yl) ethanamine; hydrochloride |
C11H14N2O |
66-83-1 |
|
| 3-Aminobenzoic acid |
C7H7NO2 |
99-05-8 |
|
| 2-(2-(Diethylamino)ethoxy)ethyl 2-phenylbutanoate |
C18H29NO3 |
18109-80-3 |
|
| METHYL 6-AMINO-5-METHOXY-1H-INDOLE-2-CARBOXYLATE |
C11H12N2O3 |
78939-36-3 |
|
| 4-Amino pyridine-N-oxide |
C5H6N2O |
3535-75-9 |
|
| 2′-Bromo-2,6-dimethoxybiphenyl |
C14H13BrO2 |
755017-61-9 |
|
| Tetradecanamide; (Myristamide) |
C14H29NO |
638-58-4 |
|
| Pyrimidine-4-carboxylic Acid |
C5H4N2O2 |
31462-59-6 |
|
| 14-Deoxy-11,12-didehydroandrographolide |
C20H28O4 |
42895-58-9 |
|
| D-Leucine tert-Butyl Ester Hydrochloride |
C10H22ClNO2 |
13081-32-8 |
|
| 4-Fluoro-2,1,3-benzoxadiazol |
C6H3FN2O |
29270-55-1 |
|
| 1-(5-bromoquinoxalin-6-yl)thiourea |
C9H7BrN4S |
842138-74-3 |
|
| 5-CHLOROBENZIMIDAZOLE |
C7H5ClN2 |
4887-82-5 |
|
| 2-Amino-3-bromo-5-Nitro pyridine |
C5H4BrN3O2 |
15862-31-4 |
|
| 4,6-Dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine |
C8H9Cl2N5 |
352457-35-3 |
|
| 4-(chloromethyl)pentanoyl chloride |
C6H10Cl2O |
139223-88-4 |
|
| 2-(3-BROMO-5-NITROPHENYL)ACETIC ACID |
C8H6BrNO4 |
934709-48-5 |
|
| 4,6-Dichloro-2-(methylsulfonyl)pyrimidine; Alogliptin impurity |
C5H4Cl2N2O2S |
4489-34-3 |
|
| 4-(2-Bromoethoxy)benzonitrile |
C7H5NO |
767-00-0 |
|
| 4-Nitropyridine N-oxide |
C5H4N2O3 |
1124-33-0 |
|
| 3-BROMOPHENYLETHYL ALCOHOL |
C8H9BrO |
28229-69-8 |
|
| 4-Chloro-3-aminocoumarin |
C10H5ClO3 |
50329-91-4 |
|
| Zanubrutinib intermediate; (tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate) |
C29H29N5O3 |
2190506-55-7 |
|
| Zanubrutinib impurity-9 |
C29H29N5O3 |
2190506-55-7 |
|
| 3,4-dihydroxy benzonitrile |
C7H5NO2 |
17345-61-8 |
|
| 1,2-Dibromo-4,5-bis(octyloxy)benzene |
C22H36Br2O2 |
118132-04-0 |
|
| 5-BROMO-2,3-DIMETHOXYBENZALDEHYDE |
C9H9BrO3 |
71295-21-1 |
|
| Coumarin 545T |
C26H26N2O2S |
155306-71-1 |
|
| 2-Chloro-4-methylpyrimidine |
C5H5ClN2 |
13036-57-2 |
|
| 1-(3-Bromo-4-methylphenyl)ethanone |
C9H9BrO |
40180-80-1 |
|
| 5,5' [[(1,1-Dimethylethyl)imino]bis[(2-hydroxypropane- 1,3-diyl)oxy]]bis(cis-1,2,3,4-tetrahydronaphthalene-2,3- diol) |
C30H43NO8 |
67247-26-1 |
|
| 5-Azacytosine (6-Amino-1,3,5-triazin-2(1H)-one) |
C3H4N4O |
931-86-2 |
|
| 2-Vinylbenzaldehyde |
C9H8O |
28272-96-0 |
|
| (4R,12aS)-N-(4-Fluorobenzyl)-7-hydroxy-4-methyl-6,8- dioxo-3,4,6,8,12,12a-hexahydro-2H- pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
C20H20FN3O5 |
1863916-88-4 |
|
| Sorefenib impurity |
C27H23N5O6 |
2204442-52-2 |
|
| 4,7-Dichloroquinoline |
C9H5Cl2N |
86-98-6 |
|
| tert-butyl ethyl(2-oxoethyl)carbamate |
C7H14N2O3 |
35150-09-5 |
|
| 1-Phenyl-1-cyclohexene |
C12H14 |
771-98-2 |
|
| Piroctone Olamine |
C16H30N2O3 |
68890-66-4 |
|
| 6,6-Dimethyl-5,-7-dioxaspiro (2.5)octane-4,8-dione |
C8H10O4 |
5617-70-9 |
|
| 2-Biphenylmethanol |
C13H12O |
2928-43-0 |
|
| Zanubrutinib impurity-11 (tert-butyl (E)-4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate) |
C15H26N2O3 |
1799799-87-3 |
|
| FLAVOKAWIN-A |
C18H18O5 |
3420-72-2 |
|
| N-Eathyl-2-phenyl-N-(pyridin-4-ylmethyl) acrylamide |
C17H18N2O |
57322-50-6 |
|
| 1-(3,5-Dimethoxyphenyl)piperazine |
C12H18N2O2 |
53557-93-0 |
|
| Coumalic Acid |
C6H4O4 |
500-05-0 |
|
| 4-[3-Fluoro-4-[[2-(methylcarbamoyl)pyridin-4- yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
C20H18FN5O3 |
1855006-12-0 |
|
| 1-Benzyl-1H-pyrazole-4-carboxylic acid |
C11H10N2O2 |
401647-24-3 |
|
| 2,5-dimethoxybenzaldehyde |
C9H10O3 |
93-02-7 |
|
| 2-(2-(Diethylamino)ethoxy)ethyl 2-phenylacetate |
C16H25NO3 |
47092-75-1 |
|
| 4-Bromomethyl-7-methoxycoumarin |
C11H9BrO3 |
35231-44-8 |
|
| Harmalol |
C12H12N2O |
525-57-5 |
|
| Diazoxide impurity-9 |
C7H7ClN2O |
140-38-5 |
|
| L-PENCILLAMINE |
C5H11NO2S |
1113-41-3 |
|
| 1-Methylethyl 4-hydroxy-3,5-bis (1-methylethyl)benzoate |
C16H24O3 |
2095678-97-8 |
|
| Raloxifene Dimesylate Hydrochloride; Raloxifene impurity-3 |
C28H27NO4S |
84449-85-4 |
|
